<?xml version="1.0" encoding="UTF-8"?><Media xmlns:cdr="cips.nci.nih.gov/cdr" BlockedFromVOL="Yes">
 
 <MediaTitle>Selected Conditioning Regimens of Different Dose Intensities</MediaTitle>
 <PhysicalMedia>
  <ImageData>
   <ImageType>chart</ImageType>
   <ImageEncoding>JPEG</ImageEncoding>
   <Color>Color</Color>
   <Labeled>Yes</Labeled>
   <LabelName language="en">Classification of Pediatric Conditioning Regimens</LabelName><LabelName language="en">Decreasing Reliance on GVT</LabelName><LabelName language="en">TBI 1200-1400 cGy +/- CY, FLU, Thio, Etop</LabelName><LabelName language="en">BU + CY + Melphalan</LabelName><LabelName language="en">BU + CY 200mg/kg</LabelName><LabelName language="en">BU + CY 120 mg/kg</LabelName><LabelName language="en">FLU + BU (full-dose)*</LabelName><LabelName language="en">FLU + Treosulfan*</LabelName><LabelName language="en">FLU + Melphalan</LabelName><LabelName language="en">FLU + BU (low-dose)</LabelName><LabelName language="en">FLU/CY/ATG</LabelName><LabelName language="en">TBI 200 cGY + FLU</LabelName><LabelName language="en">TBI 200 cGy</LabelName><LabelName language="en">Increasing Toxicity</LabelName><LabelName language="en">Non-myeloablative</LabelName><LabelName language="en">Reduced Intensity</LabelName><LabelName language="en">Myeloablative</LabelName><LabelName language="en">Increasing Intensity</LabelName><LabelName language="en">ATG = Antithymoctye globulin</LabelName><LabelName language="en">BU = Busulfan</LabelName><LabelName language="en">cGy = Centigray</LabelName><LabelName language="en">CY = Cyclophosphamide</LabelName><LabelName language="en">Etop = Etoposide</LabelName><LabelName language="en">FLU = Fludarabine</LabelName><LabelName language="en">GVT = Graft-versus-tumor effect</LabelName><LabelName language="en">TBI = Total-body irradiation</LabelName><LabelName language="en">Thio = Thiotepa</LabelName><LabelName language="en">* These two regimens have been associated with lower rates of transplant-related mortality compared with standard myeloablative approaches and are often referred to as reduced toxicity myeloablative regimens.</LabelName><ImageDimensions>
    <HeightPixels>900</HeightPixels>
    <WidthPixels>900</WidthPixels>
   </ImageDimensions>
  </ImageData>
 </PhysicalMedia>
 
 <MediaSource>
  <OriginalSource><Creator>Board member, adapted image</Creator>
   
   
   <DateCreated>2015-09-30</DateCreated>
   
   
   <SourceFilename>Classification of Pediatric Conditioning Regimens6.jpg</SourceFilename>
   <Comment audience="Internal" date="2015-09-30" user="kuhlmanna">Changed color of second box from lavender back to original peach color, per SQK</Comment><Comment audience="Internal" date="2015-08-21" user="kuhlmanna">Changed color of second box from the top to lavender so that it matches Spanish version, per SQK</Comment><Comment audience="Internal" date="2012-03-05" user="anjamison">Color difference increased between the two middle boxes .</Comment><Comment audience="Internal" date="2012-02-13" user="anjamison">Replaced journal graphic with board-member created jpeg.</Comment>
  </OriginalSource>
 </MediaSource><PermissionInformation>
    <PermissionRequested>No</PermissionRequested>
    
    
    
    
    
    
    <SpanishTranslationPermissionRequested>No</SpanishTranslationPermissionRequested>
    
    <Comment audience="Internal" date="2014-04-15" user="akuhlmann">Copyright permission not needed; image adapted by Board member</Comment></PermissionInformation><MediaContent>
  <Categories>
   <Category>treatment</Category>
  </Categories>
  
  
  <ContentDescriptions>
   <ContentDescription audience="Health_professionals" language="en">Chart showing selected preparative regimens frequently used in pediatric HCT categorized by current definitions as non-myeloablative, reduced-intensity, or myeloablative. </ContentDescription>
  </ContentDescriptions>
  <Captions>
   <MediaCaption audience="Health_professionals" language="en">Selected preparative regimens frequently used in pediatric HCT categorized by current definitions as non-myeloablative, reduced-intensity, or myeloablative. Although FLU plus treosulfan and FLU plus busulfan (full-dose) are considered myeloablative approaches, some refer to them as <Emphasis>reduced toxicity</Emphasis> regimens.</MediaCaption>
  </Captions>
 </MediaContent>
 
 <ProcessingStatuses><ProcessingStatus>
        <ProcessingStatusValue>Processing Complete</ProcessingStatusValue>
        <ProcessingStatusDate>2015-09-30</ProcessingStatusDate>
        <EnteredBy>kuhlmanna</EnteredBy>
        
       </ProcessingStatus><ProcessingStatus>
        <ProcessingStatusValue>Ready for Publishing</ProcessingStatusValue>
        <ProcessingStatusDate>2015-09-30</ProcessingStatusDate>
        <EnteredBy>kuhlmanna</EnteredBy>
        <Comment>Updated to Classification of Pediatric Conditioning Regimens6.jpg</Comment>
       </ProcessingStatus>
  <ProcessingStatus>
        <ProcessingStatusValue>Ready for Publishing</ProcessingStatusValue>
        <ProcessingStatusDate>2013-07-31</ProcessingStatusDate>
        <EnteredBy>anjamison</EnteredBy>
        <Comment>Updated to Classification of Pediatric Conditioning Regimens_Corrected_073113.jpg</Comment>
       </ProcessingStatus><ProcessingStatus>
        <ProcessingStatusValue>Ready for Publishing</ProcessingStatusValue>
        <ProcessingStatusDate>2012-03-05</ProcessingStatusDate>
        <EnteredBy>anjamison</EnteredBy>
        
       </ProcessingStatus><ProcessingStatus>
   <ProcessingStatusValue>Ready for expert reviewer</ProcessingStatusValue>
   <ProcessingStatusDate>2012-03-05</ProcessingStatusDate>
   <EnteredBy>anjamison</EnteredBy>
   <Comment audience="Internal" date="2012-03-05" user="anjamison">Updated to Classification of Pediatric Conditioning Regimens3.jpg</Comment><Comment audience="Internal" date="2012-02-13" user="anjamison">Updated to Classification of Pediatric Conditioning Regimens4.jpg</Comment><Comment>New media doc. Pending approval and content description</Comment>
  </ProcessingStatus>
 </ProcessingStatuses>
</Media>
